InvestorsHub Logo
Followers 3
Posts 99
Boards Moderated 0
Alias Born 07/18/2016

Re: PlentyParanoid post# 5954

Sunday, 11/26/2017 6:41:35 PM

Sunday, November 26, 2017 6:41:35 PM

Post# of 7747
Appreciate your input.

I suppose its also possible that the trial has not met all primary (PFS would be very long, as phase 1 trial data seemed to indicate, being over 19 months on average per Kratz) or secondary endpoints (patients have not expired in overall survival follow-up call surveillance) and that is the reason they are not delivering an update... giving someone a chance to absorb shares inexpensively in separate corporate accounts... as a potential reason.

Hopefully someday we will find out, because an update is overdue. I would have assumed that if the company gave a 1H 2017 timeline they would have provided an update of what they did have, endpoints reached or not... wouldn't be that hard... so they are probably being baboonfaced as you say not by the CRO but likely by the suitor who wants "sumfin" fer 'nuffin'